{"0":{"index":2,"##Local ID":null,"Linking ID":"NM_145239.3:c.649dup","Gene symbol":null,"Reference sequence":"NM_145239.3","HGVS":"c.649dup","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":605751,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Pathogenic","Date last evaluated":1591315200000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":"PMID:29334453; PMID:26598493; PMID:24370076","Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":"The inherited c.649dup (p.Arg217ProfsTer8) variant identified in the PRRT2 gene is the duplication of a single nucleotide, resulting in the frameshift and premature termination of the protein approximately 8 amino acids downstream (coding exon 2\/4). This variant is found in 21 heterozygous individuals in gnomAD(v3.0), with an allele frequency of 1.49e-4. This variant is reported in ClinVar as Pathogenic (VarID:65758), and is the most common pathogenic PRRT2 variant identified in affected individuals [PMID:29334453; PMID:26598493; PMID:24370076]. Functional studies suggest this variant is subject to rapid nonsense mediated decay [PMID:25457817]. Given this, the inherited c.649dup (p.Arg217ProfsTer8) variant identified in the PRRT2 gene is reported as Pathogenic.","Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"1":{"index":3,"##Local ID":null,"Linking ID":"NM_001127221.1:c.6509G>T","Gene symbol":null,"Reference sequence":"NM_001127221.1","HGVS":"c.6509G>T","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":617106,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1591315200000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":null,"Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"2":{"index":4,"##Local ID":null,"Linking ID":"NM_014159.6:c.827A>G","Gene symbol":null,"Reference sequence":"NM_014159.6","HGVS":"c.827A>G","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":616831,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1591315200000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":null,"Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"3":{"index":5,"##Local ID":null,"Linking ID":"NM_001080.3:c.589G>A","Gene symbol":null,"Reference sequence":"NM_001080.3","HGVS":"c.589G>A","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":271980,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1591315200000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":null,"Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"4":{"index":6,"##Local ID":null,"Linking ID":"NP_001071.1:p.Val197Met","Gene symbol":null,"Reference sequence":"NP_001071.1","HGVS":"p.Val197Met","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":300486,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1591315200000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":null,"Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"5":{"index":7,"##Local ID":null,"Linking ID":"NM_031407.7:c.9514C>G","Gene symbol":null,"Reference sequence":"NM_031407.7","HGVS":"c.9514C>G","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":309590,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1590710400000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":"The hemizygous, maternally inherited c.9514C>G  (p.Leu3172Val) variant identified  in  the HUWE1 gene substitutes a well conserved Leucine for Valine at amino acid 3172\/4375 (coding exon 67\/84). This variant is absent from gnomAD(v3.0) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict  this variant to be Neutral (Provean;  score:-0.53) and Tolerated (SIFT; score:0.186) to the function of the canonical transcript. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature.    The p.Leu3172 residue is not within a mapped domain of HUWE1 (UniProtKB: Q7Z6Z7), however missense variants outside of mapped  domains have been identified in affected individuals (for Review; [PMID:32336296]).  Given the lack of compelling evidence for its pathogenicity, the hemizygous,  inherited c.9514C>G  (p.Leu3172Val)  variant identified in the HUWE1 gene is reported here as a Variant of Uncertain Significance.","Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"6":{"index":8,"##Local ID":null,"Linking ID":"NM_024298.5:c.763G>A","Gene symbol":null,"Reference sequence":"NM_024298.5","HGVS":"c.763G>A","Chromosome":null,"Start":null,"Stop":null,"Reference allele":null,"Alternate allele":null,"Variant type":null,"Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":"OMIM","Condition ID value":617188,"Preferred condition name":null,"Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1590710400000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":null,"Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null},"7":{"index":9,"##Local ID":null,"Linking ID":"ChrX:77957506_78280549dup","Gene symbol":null,"Reference sequence":null,"HGVS":null,"Chromosome":"X","Start":77957506,"Stop":78280549,"Reference allele":null,"Alternate allele":null,"Variant type":"Tandem duplication","Outer start":null,"Inner start":null,"Inner stop":null,"Outer stop":null,"Variant length":null,"Copy number":null,"Reference copy number":null,"Breakpoint 1":null,"Breakpoint 2":null,"Comment on variant":null,"Trace or probe data":null,"click '+' above this column to define sequence variants by chromosome coordinates or to define structural variants":null,"Variation identifiers":null,"Location":null,"Alternate designations ":null,"Official allele name":null,"URL":null,"click '+' above this column for more columns for variant information":null,"Condition ID type":null,"Condition ID value":null,"Preferred condition name":"Not provided","Condition category":null,"Condition uncertainty":null,"Condition comment":null,"click '+' above this column for more columns about the condition ":null,"Clinical significance":"Uncertain significance","Date last evaluated":1591920000000,"Assertion method":null,"Assertion method citation":"NYGC_Assertion_Criteria_2020.pdf","Mode of inheritance":null,"Clinical significance citations":null,"Citations or URLs for  clinical significance without database identifiers":null,"Comment on clinical significance":"The maternally inherited Xq21.1 duplication is a 323KB tandem duplication on the long arm of the X chromosome. This duplication contains 4 OMIM associated genes including full duplication of TAF9B and PGK1, as well as partial duplication of genes CYSLTR1 and ATP7A. To our current knowledge, the duplication identified  in this individual has not been reported  in the literature. Of the four OMIM associated genes within this duplication, two are disease associated. Pathogenic variants in PGK1 are associated with Phosphoglycerate kinase 1 deficiency (MIM#300653), and pathogenic variants in ATP7A are associated with Menkes disease (MIM#309400), Occipital horn syndrome (MIM#304150), and Spinal muscular atrophy, distal, X-Linked 3 (MIM#300489).  Given the uncertainty regarding the functional consequence of the Xq21.1 duplication, it is reported here as a Variant of Uncertain Significance.","Explanation if clinical significance is other or drug response":null,"Drug response condition":null,"Functional consequence":null,"Comment on functional consequence":null,"click '+' above this column for more columns about clinical significance information":null,"Collection method":null,"Allele origin":null,"Affected status":null,"Structural variant method\/analysis type":null,"Clinical features":null,"Comment on clinical features":null,"Date phenotype was evaluated":null,"Tissue":null,"Sex":null,"Age range":null,"Population Group\/Ethnicity":null,"Geographic origin":null,"Family history":null,"Indication":null,"Total number of individuals tested":null,"Number of families tested":null,"click '+' above this column to add more details of individuals tested":null,"Number of individuals with variant":null,"Number of chromosomes with variant":null,"Number of families with variant":null,"Number of families with segregation observed":null,"Secondary finding":null,"Mosaicism":null,"Number of homozygotes ":null,"Number of single heterozygotes":null,"Number of compound heterozygotes":null,"Number of hemizygotes":null,"Evidence citations":null,"Citations or URLs that cannot be represented in evidence citations column":null,"Comment on evidence":null,"click '+' above this column to add more details of testing results":null,"Test name or type":null,"Platform type":null,"Platform name":null,"Method":null,"Method purpose":null,"Method citations":null,"Software name and version":null,"Software purpose":null,"Testing laboratory":null,"Date variant was reported to submitter":null,"Testing laboratory interpretation":null,"click '+' above this column to add more methods data":null,"Comment":null,"Private comment":null,"ClinVarAccession":null,"Novel or Update":null,"Replaces ClinVarAccessions ":null}}